Chemiexcited Photodynamic Therapy Integrated in Polymeric Nanoparticles Capable of MRI Against Atherosclerosis
Open Access
- 1 May 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 17, 2353-2366
Abstract
Background: Photodynamic therapy (PDT) has achieved continued success in the treatment of tumors, but its progress in the treatment of atherosclerosis has been limited, mainly due to the low tissue-penetration ability of the excitation light for photosensitizers. Methods: In this study, we designed a chemiexcited system producing singlet oxygen in an attempt to apply PDT for the treatment of atherosclerosis without the irradiation of external light. The system designed was polymeric nanoparticles (NPs) equipped with chemical fuel and photosensitizers, cross-linked with an Fe3+–catechol complex for stabilization and magnetic resonance imaging (MRI). Results: The system (FeCNPs for short) accumulated effectively in plaques, providing persistent and enhanced T1-weighted contrast ability. FeCNPs also prevented progression of atherosclerosis via macrophage elimination, and obviously reduced plaque size and thickness revealed by T1-weighted MRI. Expression of CD68, MCP1, and TNFα was significantly reduced after treatment. However, low doses of FeCNPs exhibited better therapeutic efficacy than high doses. Furthermore, low-dose FeCNPs exhibited effective macrophage elimination in aortic arches and abdominal aortae, but inefficiency in the thoracic aorta, aortic hiatus, and aorta–iliac bifurcation. Conclusion: This study provides the first example of a combination of MRI and chemiexcited PDT for atherosclerosis, evidencing the effectiveness of PDT and providing significant pointers for developing nanotherapy on atherosclerosis.Keywords
This publication has 39 references indexed in Scilit:
- Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?Cardiovascular Therapeutics, 2017
- Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: a photodynamic therapy for atherosclerosisDiscover Nano, 2015
- Upconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathwayInternational Journal of Nanomedicine, 2015
- Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammationScience Advances, 2015
- A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammationNature Communications, 2014
- Photodynamic Therapy Using a Protease-Mediated Theranostic Agent Reduces Cathepsin-B Activity in Mouse Atheromata In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Is the Use of Fullerene in Photodynamic Therapy Effective for Atherosclerosis?CardioVascular and Interventional Radiology, 2007
- Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorine(e6)Journal of Biomedical Optics, 2006
- Clinical Potential of Photodynamic Therapy in Cardiovascular DisordersAmerican Journal of Cardiovascular Drugs, 2001
- Phototherapy of Cancer and Atheromatous Plaque with TexaphyrinsJournal of Clinical Laser Medicine & Surgery, 1996